(Q55463511)

12 July 2018

title

Biomaterial-Based Vaccine Induces Regression of Established Intracranial Glioma in Rats (English)

1 reference

DOI

https://api.crossref.org/works/10.1007/S11095-010-0361-X

21 November 2024

David J. Mooney

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21225320

21 November 2024

Ed Doherty

1 reference

12 July 2018

Tracie Fradet

1 reference

12 July 2018

Jebecka Hudak

1 reference

12 July 2018

Marie-Therese Laliberte

1 reference

12 July 2018

Omar A. Ali

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21225320

21 November 2024

William J. Bell

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21225320

21 November 2024

Dwaine F. Emerich

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21225320

21 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21225320

21 November 2024

publication date

12 January 2011

1 reference

12 July 2018

full work available at URL

http://link.springer.com/content/pdf/10.1007/s11095-010-0361-x.pdf

1 reference

https://api.crossref.org/works/10.1007/S11095-010-0361-X

http://link.springer.com/article/10.1007/s11095-010-0361-x/fulltext.html

21 November 2024

1 reference

https://api.crossref.org/works/10.1007/S11095-010-0361-X

http://link.springer.com/content/pdf/10.1007/s11095-010-0361-x

21 November 2024

1 reference

DOI

https://api.crossref.org/works/10.1007/S11095-010-0361-X

21 November 2024

published in

Pharmaceutical Research

1 reference

12 July 2018

volume

1 reference

12 July 2018

issue

1 reference

12 July 2018

page(s)

1074-1080

1 reference

12 July 2018

Brain tumor immunotherapy with type-1 polarizing strategies

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0361-X

TLR ligands in the local treatment of established intracerebral murine gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0361-X

Immunotherapy of diffuse gliomas: biological background, current status and future developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0361-X

Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0361-X

IL-12 + GM-CSF microsphere therapy induces eradication of advanced spontaneous tumors in her-2/neu transgenic mice but fails to achieve long-term cure due to the inability to maintain effector T-cell activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0361-X

Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0361-X

21 January 2018

DC-based cancer vaccines

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0361-X

Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0361-X

Drug delivery systems: entering the mainstream

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0361-X

Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0361-X

Infection-mimicking materials to program dendritic cells in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0361-X

Injectable hydrogels providing sustained delivery of vascular endothelial growth factor are neuroprotective in a rat model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0361-X

Intravesical immunotherapy of superficial bladder cancer with chitosan/interleukin-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0361-X

Materials engineering for immunomodulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0361-X

Immunotherapy for recurrent malignant glioma: an interim report on survival

21 January 2018

1 reference

12 December 2020

Sustained interferon-gamma delivery from a photocrosslinked biodegradable elastomer

1 reference

12 December 2020

Human autologous tumor-specific T-cell responses induced by liposomal delivery of a lymphoma antigen

1 reference

12 December 2020

Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality

1 reference

12 December 2020

Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres

1 reference

12 December 2020

In vivo glioblastoma growth is reduced by apyrase activity in a rat glioma model.

1 reference

12 December 2020

Taking dendritic cells into medicine

1 reference

12 December 2020

Polymeric system for dual growth factor delivery

1 reference

12 December 2020

In situ regulation of DC subsets and T cells mediates tumor regression in mice

1 reference

12 December 2020

Identifiers

DOI

1 reference

12 July 2018

1 reference

12 July 2018